AKT1 and neoplasm: KEGG pathway enrichment results indicated that HLJDD might work through cell apoptosis pathway, PI3K-AKT, mitogen-activated protein kinase (MAPK) and nuclear factor-kappa B (NF-κB) etc. signaling pathway to produce the anti-tumor effect on OSCC.